Zejula 100 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FT7VH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,863
Award facts
- Contract value 100% obligated
- $12,862.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $12,862.80 delivery order to Amerisourcebergen Drug Corp on March 12, 2026, for ZEJULA 100 mg tablets (neplasib), 30-count units, with a firm fixed price and an ultimate completion date of April 2, 2026.
Place of performance is Conshohocken, PA. The order carries no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FT7VH?
SPE2DR26FT7VH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 12, 2026.
How much is contract SPE2DR26FT7VH worth?
The government has obligated $12,863 on SPE2DR26FT7VH.
Is contract SPE2DR26FT7VH an order under another contract?
Yes. SPE2DR26FT7VH is a delivery order under SPE2DR25D3201, an indefinite delivery contract.
Was contract SPE2DR26FT7VH competed?
The extent of competition for SPE2DR26FT7VH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award